This phospho-inhibition of TXNIP-regulated protein trafficking also occurs in liver and breast cancer cell lines that are treated with growth factor; however, the kinase responsible in this case is not AMPK, but is rather protein kinase B (AKT) [14]. The gene discussed is AKT1; the disease is breast cancer.